SAFE THERAPY FOR JOINT AND BACK PAIN IN A PATIENT WITH COMORBIDITY

DOI: https://doi.org/10.29296/25877305-2018-05-18
Download full text PDF
Issue: 
5
Year: 
2018

V. Shishkova, Candidate of Medical Sciences Center for Speech Pathology and Neurorehabilitation, Moscow

Тhe paper considers the pathogenic relationship of the development of articular pathology in the most common vascular diseases. It discusses current guidelines for the therapy of osteoarthritis and back pain.
Keywords: 
therapy
comorbidity
cardiovascular diseases
osteoarthritis
back pain
Capsicam
Viprosal B

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Zabolevaemost' naselenija Rossii v 2007 godu. Statisticheskie materialy / M., 2008.
  2. Breivik H., Collett B., Ventafhdda V. et al. Survey of chronic pain in Europe:Prevalence, impact on daily life, and treatment // Eur. J. Pain. – 2006; 10: 287–333.
  3. Neogi T., Zhang Y. Epidemiology of osteoarthritis // Rheum. Dis. Clin. North Am. – 2013; 39 (1): 1–19.
  4. Nguyen U., Zhang Y., Zhu Y. et al. Increasing prevalence of knee pain and symptomatic knee osteoarthritis: survey and cohort data // Ann. Intern. Med. – 2011; 155: 725–32.
  5. Nasonova V.A. Osteoartroz – problema polimorbidnosti // Consilium Medicum. – 2009; 11 (2): 5–8.
  6. Matrosov D.N., Galushko E.A., Erdes Sh.F. Epidemiologija bolej v nizhnej chasti spiny v ambulatornoj praktike // Bol'. – 2009; 4 (25): 23–8.
  7. Feinstein A. Pre-therapeutic classification of co-morbidity in chronic disease // J. Chronic Dis. – 1970; 23 (7): 455–68.
  8. Kraemer H. Statistical issues in assessing comorbidity // Stat. Med. – 1995; 14: 721–3.
  9. Van den Akker M., Buntinx F., Roos S. et al. Comorbidity or multimorbidity: what’s in a name? A review of the literature // Eur. J. Gen. Pract. – 1996; 2 (2): 65–70.
  10. Fortin M., Lapointe L., Hudon C. et al. Multimorbidity and quality of life in primary care: a systematic review // Health Qual Life Outcomes. – 2004; 20 (2): 51.
  11. Boyd C. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for performance // JAMA. – 2005; 294 (6): 716–24.
  12. Caughey G., Vitry A., Cibert A. Prevalence of comorbidity of chronic diseases in Australia // BMC Public Health. – 2008; 8: 221.
  13. Alekseeva L.I. Rekomendatsii po vedeniju bol'nyh osteoartrozom kolennyh sustavov v real'noj vrachebnoj praktike // Lechaschij vrach. – 2015; 1: 25–30.
  14. Bijlsma J., Berenbaum F., Lafeber F. Osteoarthritis: an update with relevance for clinical practice // Lancet. – 2011; 377: 2115–26.
  15. Nasonova V.A., Mendel' O.I., Denisov L.N, i dr. Osteoartroz i ozhirenie: kliniko-patogeneticheskie vzaimosvjazi // Profilakt. meditsina. – 2011; 1: 29–37.
  16. Hart D., Spector T. The relationship of obesity, fatdistribution and osteoarthritis in women in the general population: The Chingford Study // J. Rheumatol. – 1993; 20: 331–5.
  17. Felson D., Goggins J., Niu J. et al. The effect of body weight on progression of knee osteoarthritis is dependent on alignment // Arthrit. Rheum. – 2004; 50: 3904–9.
  18. Shishkova V.N. Ozhirenie i osteoporoz // Osteoporoz i osteopatii. – 2011; 1: 21–6.
  19. Aspden R., Scheven B., Hutchison J. Osteoarthritis as a systemic disorder including stromal cell differentiation and lipid metabolism // Lancet. – 2001; 357: 1118–20.
  20. McAlindon T., Bannuru R., Sullivan M. et al. OARSI guidelines for the non-surgical management of knee osteoarthritis // Osteoarthritis Cartilage. – 2014; 22: 363–88.
  21. Bruyère O., Cooper C., Pelletier J.-P. et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) // Sem. Arthrit. Rheum. – 2014: 2–11.
  22. Klinicheskie rekomendatsii. Osteoartrit. Diagnostika i vedenie bol'nyh osteoartritom kolennyh i tazobedrennyh sustavov. Pod red. O.M. Lesnjak / M.: GEOTAR-Media, 2006; 176 s.
  23. Nasonov E.L., Lazebnik L.B., Belenkov Ju.N. Primenenie nesteroidnyh protivovospalitel'nyh preparatov. Klinicheskie rekomendatsii / M.: Almaz, 2006; 88 s.
  24. Warksman J. Nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk // Ann. Rharmacother. – 2007; 41: 1163–73.
  25. Protokol soveta ekspertov severo-zapadnogo okruga Rossijskoj Federatsii po voprosam regional'nogo podhoda v lechenii bolevogo sindroma i vospalenija v nevrologii // Med. sovet. – 2015; 7: 14.
  26. Shishkova V.N. Osobennosti sovremennoj komorbidnoj patologii i vozmozhnosti korrektsii v praktike terapevta // Poliklinika (Spetsvyp. Nevrologija). – 2016; 1: 58–65.
  27. Hochberg M., Altman R., April K. et al. American College of Rheumatology 2012. Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee // Arthrit. Care Res. – 2012; 64 (4): 465–74.
  28. Badokin V.V. Viprosal V v terapii revmaticheskih zabolevanij // Rus. med. zhurn. Revmatologija. – 2011; 10: 632–5.
  29. Szolcsanyi J. Capsaicin and sensory neurones: A historical perspective // Prog. Drug Res. – 2014; 68: 1–37.
  30. Nagy I., Friston D., Valente J. et al. Pharmacology of the capsaicin receptor,transient receptor potential vanilloid type-1 ion channel // Prog. Drug Res. – 2014; 68: 39–76.
  31. Luo X., Peng J., Li Y. Recent advances in the study on capsaicinoids and capsinoids // Eur. J. Pharmacol. – 2011; 650: 1–7.
  32. Airaksinen O., Brox J., Cedraschi C. et al. COST B13 Working Group on Guidelines for Chronic Low Back Pain. Ch. 4. European guidelines for the management of chronic nonspecific low back pain // Eur. Spine J. – 2006; 15 (Suppl. 2): 192–300.
  33. Konopleva M.M. Lekarstvennoe syr'e zhivotnogo proishozhdenija i prirodnye produkty // Vestn. farmatsii. – 2012; 1 (55): 74–82.
  34. Habriev R.U., Kamaev N.O., Danilova T.I. i dr. Osobennosti dejstvija gialuronidaz razlichnogo proishozhdenija na soedinitel'nuju tkan' // Biomed. himija. – 2016; 62 (1): 82–8.